Urgent.News

What's breaking now, across thousands of outlets.

Culture

Moderna's $2B offering; AstraZeneca-Amgen and Biokin chalk up Phase 3 wins

Plus news about Takeda China and ProFound. Moderna's $2B offering: The mRNA biotech will offer convertible senior notes for the "flexibility to invest" in growing its oncology business and repay debt ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Culture

More from Thursday 27 August →